Supervisory Board Member
Dr. Nancy Simonian
Member of the Supervisory Board
[#effective April 2024, elected until 2028#]
Independent Consultant
Memberships in comparable supervising bodies of German or foreign corporations:
• Alltrna, Inc. (Board of Directors)
• Syros Pharmaceuticals, Inc. (Board of Directors)1
1listed company
Curriculum Vitae
| December 14, 1960 | born in Lake Forest, USA |
| 1983 | Bachelor’s degree in biology from Princeton University, USA |
| 1988 | M.D. degree from University of Pennsylvania, USA |
| 1988 – 1989 | Intern Internal Medicine at Massachusetts General Hospital, USA |
| 1989 – 1992 | Resident Neurology at Massachusetts General Hospital, USA |
| 1992 – 1994 | Assistant Professor and Instructor of Neurology at Harvard Medical School, USA |
| 1995 – 1997 | Associate Director of Medical Research at Biogen, Inc., USA |
| 1997 – 2000 | Director of Medical Research at Biogen, Inc., USA |
| 2000 – 2001 | Senior Director of Medical Research at Biogen, Inc., USA |
| 2001 | Vice President of Medical Research and Development at Biogen, Inc., USA |
| 2001 – 2003 | Vice President of Clinical Development at Millenium Pharmaceuticals, Inc., USA |
| 2003 – 2005 | Senior Vice President of Clinical Development at Millenium Pharmaceuticals, Inc., USA |
| 2005 – 2006 | Senior Vice President of Clinical, Medical and Regulatory Affairs at Millenium Pharmaceuticals, Inc., USA |
| 2006 – 2011 | Chief Medical Officer at Millenium Pharmaceuticals, Inc. (since 2008 Millennium: The Takeda Oncology Company), USA |
| 2012 – 2023 | Chief Executive Officer at Syros Pharmaceuticals, Inc., USA |